Silexion Therapeutics Corp (SLXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,284 | -2,733 | -11,912 | -7,500 | -4,238 |
| Depreciation Amortization | 5 | 2 | 14 | 11 | 7 |
| Accounts payable and accrued liabilities | 393 | 125 | -142 | 17 | -237 |
| Other Working Capital | -703 | -1,264 | 601 | -704 | -1,097 |
| Other Operating Activity | 18 | 224 | 620 | 373 | 605 |
| Operating Cash Flow | $-6,571 | $-3,646 | $-10,819 | $-7,803 | $-4,960 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -9 | -7 | -7 |
| Purchase Of Investment | -1 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -5 | 0 | 0 |
| Investing Cash Flow | $-1 | $0 | $-14 | $-7 | $-7 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | N/A | N/A | -696 | -696 |
| Common Stock Issued | 3,069 | 83 | 18,680 | 18,680 | 9,140 |
| Other Financing Activity | -246 | 0 | -3,040 | -2,123 | -1,207 |
| Financing Cash Flow | $2,823 | $83 | $15,640 | $15,861 | $7,237 |
| Exchange Rate Effect | -6 | -14 | -2 | 3 | 4 |
| Beginning Cash Position | 6,075 | 6,075 | 1,270 | 1,270 | 1,270 |
| End Cash Position | 2,320 | 2,498 | 6,075 | 9,324 | 3,544 |
| Net Cash Flow | $-3,749 | $-3,577 | $4,805 | $8,054 | $2,270 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,571 | -3,646 | -10,819 | -7,803 | -4,960 |
| Capital Expenditure | 0 | 0 | -9 | -7 | -7 |
| Free Cash Flow | -6,571 | -3,646 | -10,828 | -7,810 | -4,967 |